Antibody testing in aspergillosis - Quo vadis?

Medical Mycology

Volumn 53, Issue 5, 2015, Pages 417-439

  Page, Iain D ^a,b,c   Richardson, Malcolm ^a,b,c   Denning, David W ^a,b,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ABPA; Aspergillosis; Aspergillus; CPA; Serology

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; FUNGUS ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBODY RESPONSE; ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; ASYMPTOMATIC INFECTION; BRONCHITIS; CHRONIC DISEASE; COMPLEMENT FIXATION TEST; COUNTER IMMUNOELECTROPHORESIS; CUTANEOUS ASPERGILLOSIS; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE ASPERGILLOSIS; LABORATORY TEST; LUNG ASPERGILLOSIS; PRECIPITATION; REPRODUCIBILITY; REVIEW; TREATMENT RESPONSE; BLOOD; HYPERSENSITIVITY; PROCEDURES; PULMONARY ASPERGILLOSIS; SEROLOGY;

ANTIBODIES, FUNGAL; CHRONIC DISEASE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PULMONARY ASPERGILLOSIS; SEROLOGIC TESTS;

EID: 84942112219     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myv020     Document Type: Review

References (194)

1. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121(6): 1988-1999.
2. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43(Suppl 1): S207-S238.
3. Hogan C, Denning DW. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin Respir Crit Care Med 2011; 32(6): 682-692.
4. Agarwal R, Chakrabarti A, Shah A et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013; 43(8): 850-873.
5. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37(Suppl 3):S265-S280.
6. Nam H-S, Jeon K, Um S-W et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 2010; 14(6): e479-e482.
7. Ohba H, Miwa S, Shirai M et al. Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 2012; 106(5): 724-729.
8. Jhun BW, Jeon K, Eom JS et al. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. Med Mycol 2013; 51(8): 811-817.
9. Agarwal R, Nath A, Aggarwal AN et al. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses 2010; 53(2): 138-143.
10. Chakrabarti A, Singh R. The emerging epidemiology of mould infections in developing countries. Curr Opin Infect Dis 2011; 24(6): 521-526.
11. Denning D, Pleuvry A, Cole D. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 2011; 89(12): 864-872.
12. Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J 2013; 41(3): 621-626.
13. Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 2013; 51(4): 361-370.
14. Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 2011; 37(4): 865-872.
15. Chen Q-K, Jiang G-N, Ding J-A. Surgical treatment for pulmonary aspergilloma: a 35-year experience in the Chinese population. Interact Cardiovasc Thorac Surg 2012; 15(1): 77-80.
16. Ba M, Ciss G, Diarra O et al. [Surgical aspects of pulmonary aspergilloma in 24 patients]. Dakar médical 2000; 45(2): 144-146.
17. Wark PAB, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane database Syst Rev 2004; (3): CD001108.
18. Agarwal R, Vishwanath G, Aggarwal AN et al. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses 2013; 56(5): 559-570.
19. Von Eiff M, Roos N, Schulten R et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62(6): 341-347.
20. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347(6): 408-415.
21. Farid S, Mohamed S, Devbhandari M et al. Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a national centre's experience. J Cardiothorac Surg 2013; 8(1): 180.
22. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135(3): 805-826.
23. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5(10): 609-622.
24. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42(10): 1417-1427.
25. Meersseman W, van de Casteele SJ, Wilmer A et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170(6): 621-625.
26. Lu Y, Chen Y-Q, Guo Y-L et al. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis. Intern Med 2011; 50(22): 2783-2791.
27. Thornton CR. Detection of invasive aspergillosis. Adv Appl Microbiol 2010; 70: 187-216.
28. Arvanitis M, Anagnostou T, Fuchs BB et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev 2014; 27(3): 490-526.
29. ECDC. European Centre for Disease Prevention and Control. Risk assessment on the impact of environmental usage of triazoles on the development and spread of resistance to medical triazoles in Aspergillus species. Stockholm: http://www.ecdc.europa.eu/en/publications/publicat.
30. Van den Bergh MF, Verweij PE, Voss A. Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment. Diagn Microbiol Infect Dis 1999; 34(3): 221-227.
31. Guinea J, Peláez T, Alcalá L et al. Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area. Med Mycol 2006; 44(4): 349-356.
32. Tudela JLR, Sorrell TC. GAFFI Fact Sheet Fungal Keratitis. Glob Action Fund Fungal Infect. Available at: http://gaffi.org/wp-content/uploads/GAFFI-Fungal-Keratitis-briefing-2.pdf. Accessed November 24, 2013.
33. Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect 2013; 19(3): 210-220.
34. Tarazi AE, Al-Tawfiq JA, Abdi RF. Fungal malignant otitis externa: pitfalls, diagnosis, and treatment. Otol Neurotol 2012; 33(5): 769-773.
35. Bonifaz A, Cruz-Aguilar P, Ponce RM. Onychomycosis by molds. Report of 78 cases. Eur J Dermatol 2007; 17(1): 70-72.
36. Gianni C, Cerri A, Crosti C. Non-dermatophytic onychomycosis. An underestimated entity? A study of 51 cases. Mycoses 2000; 43(1-2): 29-33.
37. Tunnicliffe G, Schomberg L, Walsh S et al. Airway and parenchymal manifestations of pulmonary aspergillosis. Respir Med 2013; 107(8): 1113-1123.
38. Guitard J, Sendid B, Thorez S et al. Evaluation of a recombinant antigen-based enzyme immunoassay for the diagnosis of noninvasive aspergillosis. J Clin Microbiol 2012; 50(3): 762-765.
39. Chrdle A, Mustakim S, Bright-Thomas RJ et al. Aspergillus bronchitis without significant immunocompromise. Ann N Y Acad Sci 2012; 1272(1): 73-85.
40. Shoseyov D, Brownlee KG, Conway SP et al. Aspergillus bronchitis in cystic fibrosis. Chest 2006; 130(1): 222-226.
41. Chakrabarti A, Denning DW, Ferguson BJ et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope 2009; 119(9): 1809-1818.
42. Chakrabarti A, Chatterjee SS, Das A et al. Invasive aspergillosis in developing countries. Med Mycol 2011; 49(Suppl 1): S35-S47.
43. Kemper CA, Hostetler JS, Follansbee SE et al. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis 1993; 17(3): 344-352.
44. Cornet M, Fleury L, Maslo C et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002; 51(4): 288-296.
45. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006; 173(7): 707-717.
46. Marr KA, Carter RA, Boeckh M et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100(13): 4358-4366.
47. Mehrad B, Paciocco G, Martinez FJ et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119(1): 169-175.
48. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG). Clin Infect Dis 2008; 46(12): 1813-1821.
49. Gefter WB, Weingrad TR, Epstein DM et al. "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of Aspergillus infections of the lung. Radiology 1981; 140(2): 313-321.
50. Schweer KE, Bangard C, Hekmat K et al. Chronic pulmonary aspergillosis. Mycoses 2013; 57: 257-270.
51. Binder RE, Faling LJ, Pugatch RD et al. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 1982; 61(2): 109-124.
52. Denning DW, Follansbee SE, Scolaro M et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324(10): 654-662.
53. Hagiwara E, Sekine A, Sato T et al. [Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease]. Nihon Kokyuki Gakkai Zasshi 2008; 46(11): 864-869.
54. Pratap H, Dewan RK, Singh L et al. Surgical treatment of pulmonary aspergilloma: a series of 72 cases. Indian J Chest Dis Allied Sci 2002; 49(1): 23-27.
55. Kim YT, Kang MC, Sung SW et al. Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma. Ann Thorac Surg 2005; 79(1): 294-298.
56. Sagan D, Goździuk K. Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy. Ann Thorac Surg 2010; 89(5): 1603-1610.
57. Leading International Fungal Education. LIFE chronic pulmonary aspergillosis factsheet. http://www.life-worldwide.org/chronic-pulmonary-as. Available at: http://www.lifeworldwide.org/chronic-pulmonary-aspergillosis1 ./Accessed November 24, 2013.
58. Felton TW, Baxter C, Moore CB et al. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 2010; 51(12): 1383-1391.
59. Shin B, Koh W-J, Jeong B-H et al. Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis. J Infect 2014; 68(5): 494-499.
60. Kitasato Y, Tao Y, Hoshino T et al. Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis. Respirology 2009; 14(5): 701-708.
61. Denning DW, Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52(9): 1123-1129.
62. Agarwal R, Maskey D, Aggarwal AN et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: A latent class analysis. PLoS One 2013; 8(4): 1-7.
63. Zureik M, Neukirch C, Leynaert B et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002; 325(7361): 411-414.
64. Denning DW, O'Driscoll BR, Hogaboam CM et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27(3): 615-626.
65. Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009; 179(1): 11-18.
66. Baxter CG, Dunn G, Jones AM et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol 2013; 132: 560-566.
67. Agarwal R, Gupta D, Aggarwal AN et al. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007; 132(4): 1183-1190.
68. Aimanianda V, Bayry J, Bozza S et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 2009; 460(7259): 1117-1121.
69. Lass-Flörl C, Salzer GM, Schmid T et al. Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients. Br J Haematol 1999; 104(4): 745-747.
70. Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev 2009; 22(4): 535-551.
71. Bardana EJ. Measurement of humoral antibodies to aspergilli. Ann N Y Acad Sci 1974; 221:64-75.
72. Van Hoeyveld E, Dupont L, Bossuyt X. Quantification of IgG antibodies to Aspergillus fumigatus and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique? Clin Chem 2006; 52(9): 1785-1793.
73. Baxter CG, Denning DW, Jones AM et al. Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin Microbiol Infect 2013; 19(4): E197-E204.
74. Iwata H, Miwa T, Takagi K. [Tuberculosis sequelae: secondary fungal infections]. Kekkaku 1990; 65(12): 867-871.
75. British Tuberculosis Association. Aspergilloma and residual tuberculous cavities - The results of a resurvey. Tubercle 1970; 51:227-245.
76. Chu C-M, Woo PCY, Chong KTK et al. Association of presence of Aspergillus antibodies with hemoptysis in patients with old tuberculosis or bronchiectasis but no radiologically visible mycetoma. J Clin Microbiol 2004; 42(2): 665-669.
77. Barton RC, Hobson RP, Denton M et al. Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus. Diagn Microbiol Infect Dis 2008; 62(3): 287-291.
78. Sharma GL, Bhatnagar PK, Chattopadhya D et al. Analysis of HIV seropositive thalassemic children for antibodies specific to Aspergillus fumigatus by luminescent immunoassay. J Clin Lab Anal 1997; 11(6): 343-345.
79. Ferreira-Da-Cruz MF, Wanke B, Pirmez C et al. Aspergillus fumigatus fungus ball in hospitalized patients with chronic pulmonary disease. Usefulness of double immunodiffusion test as a screening procedure. Mem Inst Oswaldo Cruz 1988; 83(3): 357-360.
80. Young RC, Bennett JE. Invasive aspergillosis. Absence of detectable antibody response. Am Rev Respir Dis 1971; 104(5): 710-716.
81. Holmberg K, Berdischewsky M, Young LS. Serologic immunodiagnosis of invasive aspergillosis. J Infect Dis 1980; 141(5): 656-664.
82. Matthews R, Burnie JP, Fox A et al. Immunoblot analysis of serological responses in invasive aspergillosis. J Clin Pathol 1985; 38(11): 1300-1303.
83. Kappe R, Schulze-Berge A, Sonntag HG. Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis. Mycoses 1996; 39(1-2): 13-23.
84. Manso E, Montillo M, De Sio G et al. Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1994; 13(9): 756-760.
85. Kappe R, Rimek D. [Antibody detection in patients with invasive aspergillosis]. Mycoses 2004; 47(Suppl 1): 55-59.
86. Mishra SK, Falkenberg S, Masihi KN. Efficacy of enzyme-linked immunosorbent assay in serodiagnosis of aspergillosis. J Clin Microbiol 1983; 17(4): 708-710.
87. Weig M, Frosch M, Tintelnot K et al. Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol 2001; 39(5): 1721-1730.
88. Du C, Wingard JR, Cheng S et al. Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis. Biol Blood Marrow Transplant. 2012; 18(12): 1927-1934.
89. Cornillet A, Camus C, Nimubona S et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006; 43(5): 577-584.
90. Felton TW, Roberts SA, Isalska B et al. Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortality. J Infect. 2012; 65(4): 350-356.
91. Trull AK, Parker J, Warren RE. IgG enzyme linked immunosorbent assay for diagnosis of invasive aspergillosis: retrospective study over 15 years of transplant recipients. J Clin Pathol 1985; 38(9): 1045-1051.
92. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12(2): 310-350.
93. Centeno-Lima S, de Lacerda JM, do Carmo JA et al. Follow-up of anti-Aspergillus IgG and IgA antibodies in bone marrow transplanted patients with invasive aspergillosis. J Clin Lab Anal 2002; 16(3): 156-162.
94. Tomee JF, Mannes GP, van der Bij W et al. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation. Ann Intern Med 1996; 125(3): 197-201.
95. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20(7): 1898-1906.
96. Pinel C, Fricker-Hidalgo H, Lebeau B et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003; 41(5): 2184-2186.
97. Longbottom JL, Pepys J. Pulmonary aspergillosis: diagnostic and immunological significance of antigens and c-substance in Aspergillus fumigatus. J Pathol Bacteriol 1964; 88: 141-151.
98. Schønheyder H, Andersen P. An indirect immunofluorescence study of antibodies to Aspergillus fumigatus in sera from children and adults without aspergillosis. Sabouraudia 1982; 20(1): 41-50.
99. Kostiala AI, Stenius-Aarniala B, Alanko K. Analysis of antibodies to Aspergillus fumigatus antigens by class-specific enzyme-linked immunosorbent assay in patients with pulmonary aspergillosis. Diagn Microbiol Infect Dis 1984; 2(1): 37-49.
100. Kauffman HF, van der Heide S, Beaumont F et al. Class-specific antibody determination against Aspergillus fumigatus by means of the enzyme-linked immunosorbent assay. III. Comparative study: IgG, IgA, IgM ELISA titers, precipitating antibodies and IgE binding after fractionation of the antigen. Int Arch Allergy Appl Immunol 1986; 80(3): 300-306.
101. Yamamoto S, Toida I, Wada M et al. [Serological diagnosis of pulmonary aspergillosis by ELISA]. Kekkaku 1989; 64(1): 15-24.
102. Ninomiya H, Harada S, Harada Y et al. [Serological diagnosis of pulmonary aspergillosis-measurement of IgG-, IgMand IgA- antibodies against Aspergillus fumigatus by means of ELISA]. Kekkaku 1990; 65(4): 263-272.
103. Bozza S, Clavaud C, Giovannini G et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol 2009; 183(4): 2407-2414.
104. Brouwer J. Detection of antibodies against Aspergillus fumigatus: comparison between double immunodiffusion, ELISA and immunoblot analysis. Int Arch Allergy Appl Immunol 1988; 85(2): 244-249.
105. Longbottom JL, Pepys J, Clive FT. Diagnostic precipitin test in Aspergillus pulmonary mycetoma. Lancet 1964; 1(7333): 588-589.
106. Tomee JF, van der Werf TS, Latge JP et al. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med 1995; 151(1): 199-204.
107. Jain LR, Denning DW. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J Infect 2006; 52(5): e133-e137.
108. Camuset J, Nunes H, Dombret M-C et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 2007; 131(5): 1435-1441.
109. Cadranel J, Philippe B, Hennequin C et al. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis.2012; 31(11): 3231-3239.
110. Chishimba L, Niven RM, Cooley J et al. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma 2012; 49(4): 423-433.
111. Ryan MW, Marple BF. Allergic fungal rhinosinusitis: diagnosis and management. Curr Opin Otolaryngol Head Neck Surg 2007; 15(1): 18-22.
112. Schubert MS. Allergic fungal sinusitis: pathophysiology, diagnosis and management. Med Mycol 2009; 47(Suppl 1): S324-S330.
113. Wang JL, Patterson R, Rosenberg M et al. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978; 117(5): 917-927.
114. Greenberger PA, Patterson R. Application of enzyme-linked immunosorbent assay (ELISA) in diagnosis of allergic bronchopulmonary aspergillosis. J Lab Clin Med 1982; 99(2): 288-293.
115. Stevens DA, Schwartz HJ, Lee JY et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342(11): 756-762.
116. Wark PAB, Hensley MJ, Saltos N et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111(5): 952-957.
117. Chishimba L, Niven RM, Cooley J et al. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J asthma 2012; 49(4): 423-433.
118. McCarthy DS, Simon G, Hargreave FE. The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol 1970; 21(4): 366-375.
119. Menon MP, Das AK. Allergic bronchopulmonary aspergillosis (radiological aspects). Indian J Chest Dis Allied Sci 1977; 19(4): 157-169.
120. Kurup VP, Resnick A, Kalbfleish J et al. Antibody isotype responses in Aspergillus-induced diseases. J Lab Clin Med 1990; 115(3): 298-303.
121. Rosenberg M, Patterson R, Roberts M et al. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978; 64(4): 599-606.
122. Wang JL, Patterson R, Roberts M et al. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1979; 120(1): 87-92.
123. Denning DW, van Wye JE, Lewiston NJ et al. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991; 100(3): 813-819.
124. Ouchterlony O. Antigen-antibody reactions in gels. Acta Pathol Microbiol Scand 1949; 26(4): 507-515.
125. Pepys J, Riddell R, Clayton Y. Human precipitins against common pathogenic and non-pathogenic fungi. Nature 1959; 183: 296.
126. Racine R, Winslow GM. IgM in microbial infections: taken for granted? Immunol Lett 2009; 125(2): 79-85.
127. MacKenzie DW. Serological tests. In: Evans E, Richardson MD, eds. Medical Mycology: a practical approach. 1st ed. Oxford: IRL Press; 1989: 201-234.
128. Ikemoto H, Shibata S. Indirect haemagglutination in pulmonary aspergilloma diagnosis. Sabouraudia 1973; 11(2): 167-170.
129. Tönder O, Rödsaethier M. Indirect haemagglutination for demonstration of antibodies to Aspergillus fumigatus. Acta Pathol Microbiol Scand B Microbiol Immunol 1974; 82(6): 871-878.
130. Smith CE, Saito MT, Beard RR et al. Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am J Hyg 1950; 52(1): 1-21.
131. Sepulveda R, Longbottom JL, Pepys J. Enzyme linked immunosorbent assay (ELISA) for IgG and IgE antibodies to protein and polysaccharide antigens of Aspergillus fumigatus. Clin Allergy 1979; 9(4): 359-371.
132. Richardson MD, Stubbins JM, Warnock DW. Rapid enzyme-linked immunosorbent assay (ELISA) for Aspergillus fumigatus antibodies. J Clin Pathol 1982; 35(10): 1134-1137.
133. Kim SJ, Chaparas SD, Brown TM et al. Characterization of antigens from Aspergillus fumigatus. II. Fractionation and electrophoretic, immunologic, and biologic activity. Am Rev Respir Dis 1978; 118(3): 553-560.
134. Piechura JE, Huang CJ, Cohen SH et al. Antigens of Aspergillus fumigatus. II. Electrophoretic and clinical studies. Immunology 1983; 49(4): 657-665.
135. Kurup VP, Fink JN, Scribner GH et al. Antigenic variability of Aspergillus fumigatus strains. Microbios 1977; 19(77-78): 191-204.
136. Kim SJ, Chaparas SD, Buckley HR. Characterization of antigens from Aspergillus fumigatus. IV. Evaluation of commercial and experimental preparations and fractions in the detection of antibody in aspergillosis. Am Rev Respir Dis 1979; 120(6): 1305-1311.
137. Thurston JR, Richard JL, McMillen S. Cultural and serological comparison of ten strains of Aspergillus fumigatus Fresenius. Mycopathol Mycol Appl 1973; 51(4): 327-335.
138. Tran-van-Ky P, Torck C, Vaucelle T et al. [Comparative study on immunoelectrophoregrams of enzymes of the antigenic extract of Aspergillus fumigatus revealed by experimental serums and serums of patients with aspergillosis]. Sabouraudia 1969; 7(2): 73-84.
139. Wallenbeck I, Aukrust L, Einarsson R. Antigenic variability of different strains of Aspergillus fumigatus. Int Arch Allergy Appl Immunol 1984; 73(2): 166-172.
140. Blanco JL, García ME, Kurup VP. Immunoreactivity of antigen extracts of Aspergillus fumigatus isolated from different sources. Rev Iberoam Micol 1997; 14(2): 60-62.
141. Kurup V KA, Microbiology C. Immunodiagnosis of aspergillosis. Clin Microbiol Rev 1991; 4(4): 439-456.
142. Longbottom JL, Austwick PK. Antigens and allergens of Aspergillus fumigatus. I. Characterization by quantitative immunoelectrophoretic techniques. J Allergy Clin Immunol 1986; 78(1 Pt 1): 9-17.
143. Kurup VP, Resnick A, Scribner GH et al. Enzyme profile and immunochemical characterization of Aspergillus fumigatus antigens. J Allergy Clin Immunol 1986; 78(6): 1166-1173.
144. Kurup VP, Resnick A, Scribner GH et al. Comparison of antigens and serological methods in Aspergillus fumigatus antibody detection. Mykosen 1984; 27(1): 43-50.
145. Bardana EJ, McClatchy JK, Farr RS et al. The primary interaction of antibody to components of aspergilli. II. Antibodies in sera from normal persons and from patients with aspergillosis. J Allergy Clin Immunol 1972; 50(4): 222-234.
146. Bardana EJ. The clinical spectrum of aspergillosis-part 2: classification and description of saprophytic, allergic, and invasive variants of human disease. Crit Rev Clin Lab Sci 1981; 13(2): 85-159.
147. Shahid M, Malik A, Bhargava R. Prevalence of aspergillosis in chronic lung diseases. Indian J Med Microbiol 2001; 19(4): 201-205.
148. Severo LC, Geyer GR, Porto NDS et al. Pulmonary Aspergillus niger intracavitary colonization. Report of 23 cases and a review of the literature. Rev Iberoam Micol 1997; 14(3): 104-110.
149. Chaparas ST, Kaufman L, Kim SJ et al. Characterization of antigens from Aspergillus fumigatus. V. Reactivity in immunodiffusion tests with serums from patients with aspergillosis caused by Aspergillus flavus, A. niger, and A. fumigatus. Am Rev Respir Dis 1980; 122(4): 647-650.
150. Hearn VM, Wilson E V, Proctor AG et al. Preparation of Aspergillus fumigatus antigens and their analysis by two-dimensional immunoelectrophoresis. J Med Microbiol 1980; 13(3): 451-458.
151. Singh B, Oellerich M, Kumar R et al. Immuno-reactive molecules identified from the secreted proteome of Aspergillus fumigatus. JProteomeRes2010; 9(11): 5517-5529.
152. Kurup VP. Aspergillus antigens: which are important? Med Mycol 2005; 43(Suppl 1): S189-S196.
153. Bowyer P, Denning DW. Genomic analysis of allergen genes in Aspergillus spp: the relevance of genomics to everyday research. Med Mycol 2007; 45(1): 17-26.
154. Sarfati J, Monod M, Recco P et al. Recombinant antigens as diagnostic markers for aspergillosis. Diagn Microbiol Infect Dis 2006; 55(4): 279-291.
155. Latgé JP, Kobayashi H, Debeaupuis JP et al. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun 1994; 62(12): 5424-5433.
156. Crameri R, Hemmann S, Ismail C et al. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998; 10(8): 1211-1216.
157. Kurup VP, Banerjee B, Hemmann S et al. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 2000; 30(7): 988-993.
158. International Union of Immunology Societies. IUIS Allergen Nomenclature Home Page. :http://www.allergen.org/index.php. Available at: http://www.allergen.org/index.php. Accessed October 6, 2013.
159. Kodzius R, Rhyner C, Konthur Z et al. Rapid identification of allergen-encoding cDNA clones by phage display and highdensity arrays. Comb Chem High Throughput Screen 2003; 6(2): 147-154.
160. Crameri R, Lidholm J, Grönlund H et al. Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia Cap System. Clin Exp Allergy 1996; 26(12): 1411-1419.
161. Arruda LK, Platts-Mills TA, Longbottom JL et al. Aspergillus fumigatus: identification of 16, 18, and 45 kd antigens recognized by human IgG and IgE antibodies and murine monoclonal antibodies. J Allergy Clin Immunol 1992; 89(6): 1166-1176.
162. Bowyer P, Fraczek M, Denning DW. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genomics 2006; 7: 251.
163. Nikolaizik WH, Moser M, Crameri R et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 1995; 152(2): 634-639.
164. Hemmann S, Nikolaizik WH, Schöni MH et al. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998; 28(4): 1155-1160.
165. Nikolaizik WH, Weichel M, Blaser K et al. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am J Respir Crit Care Med 2002; 165(7): 916-921.
166. Kurup VP, Knutsen AP, Moss RB et al. Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA. Clin Mol allergy 2006; 4(1): 11.
167. Denikus N, Orfaniotou F, Wulf G et al. Fungal antigens expressed during invasive aspergillosis. Infect Immun 2005; 73(8): 4704-4713.
168. Dee TH. Detection of Aspergillus fumigatus serum precipitins by counterimmunoelectrophoresis. J Clin Microbiol 1975; 2(6): 482-485.
169. Kauffman HF, Beaumont F, Meurs H et al. Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA). J Allergy Clin Immunol 1983; 72(3): 255-261.
170. Kurup VP, Fink JN. Evaluation of methods to detect antibodies against Aspergillus fumigatus. Am J Clin Pathol 1978; 69(4): 414-417.
171. Warnock DW. Detection of Aspergillus fumigatus precipitins: a comparison of counter immunoelectrophoresis and double diffusion. J Clin Pathol 1977; 30(4): 388-389.
172. Faux JA, Shale DJ, Lane DJ. Precipitins and specific IgG antibody to Aspergillus fumigatus in a chest unit population. Thorax 1992; 47(1): 48-52.
173. Gugnani HC, Reijula KE, Kurup VP et al. Detection of IgG and IgE antibodies to Aspergillus fumigatus in human sera by immunogold assay. Mycopathologia 1990; 109(1): 33-40.
174. Schønheyder H, Andersen P, Stenderup A. Serum antibodies to aspergillus fumigatus in patients with pulmonary aspergillosis detected by immunofluorescence. Acta Pathol Microbiol Immunol Scand B 1982; 90(4): 273-279.
175. Avila R. Immunological study of pulmonary aspergilloma. Thorax 1968; 23(2): 144-152.
176. Warren CP, Tai E, Batten JC et al. Cystic fibrosis - immunological reactions to A. fumigatus and common allergens. Clin Allergy 1975; 5(1): 1-12.
177. Mackenzie DW, Philpot CM. Counterimmunoelectrophoresis as a routine mycoserological procedure. Mycopathologia 1975; 57(1): s1-7.
178. Malo JL, Longbottom J, Mitchell J et al. Studies in chronic allergic bronchopulmonary aspergillosis 3 Immunological findings. Thorax 1977; 32: 269-274.
179. Mehta SK, Sandhu RS. Efficacy of counterimmunoelectrophoresis in the detection of fungal antibodies in allergic bronchopulmonary mycoses. Zentralbl Bakteriol A 1980; 247(4): 537-542.
180. Van Toorenenbergen AW. Between-laboratory quality control of automated analysis of IgG antibodies against Aspergillus fumigatus. Diagn Microbiol Infect Dis 2012; 74(3): 278-281.
181. Longbottom JL. Immunological aspects of infection and allergy due to Aspergillus species. Mykosen Suppl 1978; 1: 207-217.
182. Smits WL, Letz KL, Evans TS et al. Evaluating the response of patients undergoing both allergy skin testing and in vitro allergy testing with the ImmunoCAP Technology System. JAm Acad Nurse Pract 2003; 15(9): 415-423.
183. O'Driscoll BR, Powell G, Chew F et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy 2009; 39(11): 1677-1683.
184. Wood RA, Segall N, Ahlstedt S et al. Accuracy of IgE antibody laboratory results. Ann Allergy Asthma Immunol 2007; 99(1): 34-41.
185. Greenwald JL, Burstein GR, Pincus J et al. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 2006; 8(2): 125-131.
186. Murray CK, Gasser RA, Magill AJ et al. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 2008; 21(1): 97-110.
187. Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 2008; 15(7): 1095-1105.
188. Held J, Schmidt T, Thornton CR et al. Comparison of a novel Aspergillus lateral-flow device and the Platelia(®) galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection 2013; 41(6): 1163-1169.
189. Wiederhold NP, Thornton CR, Najvar LK et al. Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin Vaccine Immunol 2009; 16(12): 1844-1846.
190. Prattes J, Flick H, Prüller F et al. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med 2014: 1-27.
191. Baddley JW, Marr KA, Andes DR et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47(10): 3271-3275.
192. Kurhade AM, Deshmukh JM, Fule RP et al. Mycological and serological study of pulmonary aspergillosis in central India. Indian J Med Microbiol 2002; 20(3): 141-144.
193. Michael RC, Michael JS, Ashbee RH et al. Mycological profile of fungal sinusitis: an audit of specimens over a 7-year period in a tertiary care hospital in Tamil Nadu. Indian J Pathol Microbiol 2008; 51(4): 493-496.
194. Prateek S, Banerjee G, Gupta P et al. Fungal rhinosinusitis: a prospective study in a university hospital of Uttar Pradesh. Indian J Med Microbiol 2013; 31(3): 266-269.